Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway

被引:63
|
作者
Li, Chengyun [1 ]
Liang, Geyu [1 ]
Yang, Sheng [1 ]
Sui, Jing [1 ]
Yao, Wenzhuo [1 ]
Shen, Xian [1 ]
Zhang, Yanqiu [1 ]
Peng, Hui [1 ]
Hong, Weiwei [1 ]
Xu, Siyi [1 ]
Wu, Wenjuan [1 ]
Ye, Yancheng [2 ]
Zhang, Zhiyi [2 ]
Zhang, Wenhua [2 ]
Yin, Lihong [1 ]
Pu, Yuepu [1 ]
机构
[1] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing 210009, Jiangsu, Peoples R China
[2] Gansu Wuwei Tumor Hosp, Wuwei 733000, Gansu, Peoples R China
基金
中国国家自然科学基金;
关键词
gastric cancer; lncRNA; UCA1; progression; molecular mechanism; LONG NONCODING RNA; WESTERN-BLOT ASSAY; UCA1; CARCINOMA; EXPRESSION; RESISTANCE; INHIBITION; SURGERY; IDENTIFICATION; CELLS;
D O I
10.18632/oncotarget.19281
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) has been recently shown to be dysregulated during disease occurrence and to play an important role in the progression of several cancers. However, the biological role and potential regulation mechanism of UCA1 in the carcinogenesis of gastric cancer remain unclear. In the present study, we found that UCA1 was aberrantly upregulated in gastric cancer tissues and gastric cancer cell lines, and was associated with TNM stage and metastasis. UCA1 silencing significantly inhibited gastric cancer BGC-823 cell proliferation and increased its apoptosis. We also found that UCA1 played an important role in the migration and invasion of gastric cancer cells in vitro and in vivo. The molecular mechanism of UCA1 suggested that UCA1 regulates the PI3KAkt-mTOR signaling proteins and their downstream mediators, to alter gastric cancer progression in vitro and in vivo. Collectively, the results showed a pivotal role of UCA1 in the tumorigenesis of gastric cancer. In addition, the study characterized a novel lncRNA-mRNA regulatory network, which may lead to a better understanding of the pathogenesis of gastric cancer and assist in lncRNA-directed diagnosis and therapy for this malignancy.
引用
收藏
页码:93476 / 93491
页数:16
相关论文
共 50 条
  • [1] Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway
    Li, Chengyun
    Liang, Geyu
    Sui, Jing
    Yang, Sheng
    Xu, Siyi
    TOXICOLOGY LETTERS, 2017, 280 : S239 - S240
  • [2] LncRNA-LOC101928316 contributes to gastric cancer progression through regulating PI3K-Akt-mTOR signaling pathway
    Li, Chengyun
    Liang, Geyu
    Yang, Sheng
    Sui, Jing
    Wu, Wenjuan
    Xu, Siyi
    Ye, Yancheng
    Shen, Bo
    Zhang, Xiaomei
    Zhang, Yan
    CANCER MEDICINE, 2019, 8 (09): : 4428 - 4440
  • [3] CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway
    Jiang, Chao
    Ma, Zhenghong
    Zhang, Guoan
    Yang, Xigui
    Du, Qin
    Wang, Weibo
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 10135 - 10143
  • [4] PI3K-AKT-mTOR pathway and cancer
    Coutte, Laetitia
    Dreyer, Chantal
    Sablin, Marie-Paule
    Faivre, Sandrine
    Raymond, Eric
    BULLETIN DU CANCER, 2012, 99 (02) : 173 - 180
  • [5] GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling
    Yan, Guang
    Ru, Yi
    Wu, Kerong
    Yan, Fengqi
    Wang, Qinhao
    Wang, Jingxiang
    Pan, Tao
    Zhang, Mei
    Han, Hua
    Li, Xia
    Zou, Lian
    PROSTATE, 2018, 78 (03): : 166 - 177
  • [6] Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway
    Yang, Dongyong
    Wang, Yanqing
    Zheng, Yajing
    Dai, Fangfang
    Liu, Shiyi
    Yuan, Mengqin
    Deng, Zhimin
    Bao, Anyu
    Cheng, Yanxiang
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [7] Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway
    Dongyong Yang
    Yanqing Wang
    Yajing Zheng
    Fangfang Dai
    Shiyi Liu
    Mengqin Yuan
    Zhimin Deng
    Anyu Bao
    Yanxiang Cheng
    Journal of Ovarian Research, 14
  • [8] A bibliometric analysis of the application of the PI3K-AKT-mTOR signaling pathway in cancer
    Deng, Zhengzheng
    Qing, Qiancheng
    Huang, Bo
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (10) : 7255 - 7272
  • [9] Silencing of lncRNA UCA1 Reverses Doxorubicin Resistance of Breast Cancer Through Inhibiting PI3K/AKT/mTOR Signaling Pathway
    Suicmez, Menderes
    Namalir, Gamze
    Konus, Metin
    Ozdil, Hilal
    CHEMISTRYSELECT, 2024, 9 (20):
  • [10] The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors
    Saji, Motoyasu
    Ringel, Matthew D.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 321 (01) : 20 - 28